A safety assessment of tumor necrosis factor antagonists during pregnancy: A review of the food and drug administration database

Journal of Rheumatology

Volumn 36, Issue 3, 2009, Pages 635-641

  Carter, John D ^a   Ladhani, Anil ^a   Ricca, Louis R ^a   Valeriano, Joanne ^a   Vasey, Frank B ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Pregnancy; Safety; Tumor necrosis factor antagonists

Indexed keywords

ACETYLSALICYLIC ACID; ADALIMUMAB; AMLODIPINE; CARBASALATE CALCIUM; CARISOPRODOL; CHLORPHENIRAMINE MALEATE; CYCLOBENZAPRINE; DEXTROPROPOXYPHENE; DIAZEPAM; ETANERCEPT; FAMOTIDINE; GABAPENTIN; GLIBENCLAMIDE; HYDROCHLOROTHIAZIDE; IBUPROFEN; INFLIXIMAB; LANSOPRAZOLE; LEFLUNOMIDE; LEVOFLOXACIN; LEVOTHYROXINE; LORAZEPAM; METHOTREXATE; OMEPRAZOLE; OXYCODONE; PETHIDINE; PIPERAZINE ESTRONE SULFATE; PREDNISONE; ROFECOXIB; TRIAMTERENE; UNINDEXED DRUG; ANTIRHEUMATIC AGENT; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; TNFR FC FUSION PROTEIN; TNFR-FC FUSION PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADVERSE OUTCOME; ANENCEPHALUS; ANEURYSM; ANUS ATRESIA; ARTICLE; ATRESIA; BLINDNESS; BONE DYSPLASIA; CHILD; CONGENITAL CATARACT; CONGENITAL DEAFNESS; CONGENITAL HEART DISEASE; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; CONGENITAL STRABISMUS; CYSTIC LYMPHANGIOMA; DISEASE ASSOCIATION; DRUG SAFETY; DUANE RETRACTION SYNDROME; ESOPHAGUS ATRESIA; ESOPHAGUS MALFORMATION; FALLOT TETRALOGY; FLATFOOT; FOOD AND DRUG ADMINISTRATION; HEART ATRIUM SEPTUM DEFECT; HEART DISEASE; HEART VENTRICLE SEPTUM DEFECT; HIRSCHSPRUNG DISEASE; HUMAN; HYDROCELE; HYPOKINESIA; HYPOSPADIAS; INTESTINE MALFORMATION; KIDNEY MALFORMATION; KIDNEY POLYCYSTIC DISEASE; LARYNX STENOSIS; LIMB DEFORMITY; LIMB MALFORMATION; LUNG MALFORMATION; MOTHER; OPTIC NERVE DISEASE; PES EQUINUS; PREGNANCY; PRIORITY JOURNAL; SPINE DISEASE; SYNDROME VATER; TERATOMA; TRACHEA DISEASE; TRACHEA STENOSIS; TRACHEOESOPHAGEAL FISTULA; TRISOMY 21; VERTEBRA MALFORMATION; DRUG ANTAGONISM; FEMALE; INCIDENCE; PRENATAL EXPOSURE; REGISTER; UNITED STATES;

ABNORMALITIES, DRUG-INDUCED; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; FEMALE; HUMANS; IMMUNOGLOBULIN G; INCIDENCE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RECEPTORS, TUMOR NECROSIS FACTOR; REGISTRIES; TUMOR NECROSIS FACTOR-ALPHA; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 65649134752     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.080545     Document Type: Article

References (60)

1. Chambers CD, Tutuncu ZN, Johnson D, Jones KL. Human pregnancy safety for agents used to treat rheumatoid arthritis: adequacy of available information and strategies for developing post-marketing data. Arthritis Res Ther 2006;8:215. (Pubitemid 44363221)
2. Chambers CD, Johnson DL, Jones KL. The OTIS Collaborative Research Group. Pregnancy outcome in women exposed to etanercept: The OTIS Autoimmune Diseases in Pregnancy Project [abstract]. Washington, DC: American Academy of Dermatology, Feb 3-5, 2007.
3. Chambers CD, Johnson DL, Jones KL. The OTIS Collaborative Research Group. Pregnancy outcome in women exposed to adalimumab: The OTIS Autoimmune Diseases in Pregnancy Project [abstract]. Barcelona: EULAR, June 14, 2007; THU0162.
4. Carter JD, Valeriano J, Vasey FB. Tumor necrosis factor inhibition and VATER association: a causal relationship? J Rheumatol 2006;33:1014-1017
5. Barnes JC, Smith WL. The VATER association. Radiology 1978;126:445-449 (Pubitemid 8283764)
6. Miller MT, Stromland K. Teratogen update: thalidomide: a review, with a focus on ocular findings and new potential uses. Teratology 1999;60:306-321 (Pubitemid 30265249)
7. Matthews SJ, McCoy C. Thalidomide: a review of approved and investigational uses. Clin Ther 2003;25:342-395
8. Robert E, Guibaud P. Maternal valproic acid and congenital neural tube defects. Lancet 1982;2:937.
9. Lammer EJ, Sever LE, Oakley GP Jr. Teratogen update: valproic acid. Teratology 1987:35:465-473 (Pubitemid 17106969)
10. Ichiyama T, Okada K, Lipton JM, Matsubara T, Hayashi T, Furukawa S. Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappa-B. Brain Res 2000;857:246-251 (Pubitemid 30107811)
11. Ofori B, Oraichi D, Blais L, Rey E, Bérard A. Risk of congenital anomalies in pregnant users of non-steroidal anti-inflammatory drugs: A nested case-control study. Birth Defects Res B Dev Reprod Toxicol 2006;77:268-279 (Pubitemid 44484020)
12. Centers for Disease Control and Prevention (CDC). Birth defects: frequently asked questions. Internet. Available from: http://www.cdc.gov/ncbddd/ bd/facts.htm. Accessed Oct 31 2008.
13. Toder V, Fein A, Carp H, Torchinsky A. TNF-alpha in pregnancy loss and embryo maldevelopment: a mediator of detrimental stimuli or a protector of the fetoplacental unit? J Assist Reprod Genet 2003;20:73-81.
14. Torchinsky A, Shepshelovich J, Orenstein H, et al. TNF-alpha protects embryos exposed to developmental toxicants. Am J Reprod Immunol 2003;49:159-168 (Pubitemid 36612058)
15. Toder V, Carp H, Fein A, Torchinsky A. The role of pro- and anti-apoptotic molecular interactions in embryonic maldevelopment. Am J Reprod Immunol 2002;48:235-244
16. Torchinsky A, Fein A, Toder V. Teratogen-induced apoptotic cell death: does the apoptotic machinery act as a protector of embryos exposed to teratogens? Birth Defects Res C Embryo Today 2005;75:353-361
17. Shaw GM, Iovannisci DM, Yang W, et al. Risks of human conotruncal heart defects associated with 32 single nucleotide polymorphisms of selected cardiovascular disease-related genes. Am J Med Genet A 2005;138:21-26 (Pubitemid 41262639)
18. Carmichael SL, Shaw GM, Iovannisci DM, et al. Risks of human limb deficiency anomalies associated with 29 SNP's of genes involved in homocystein metabolism, coagulation, cell-cell interactions, inflammatory response, and blood pressure regulation. Am J Med Genet A 2006;140:2433-2440 (Pubitemid 44684938)
19. Simister NE, Story CM, Chen HL, Hunt JS. An IgG-transporting Fc receptor expressed in the syncytiotrophoblast of human placenta. Eur J Immunol 1996;26:1527-1531 (Pubitemid 26229998)
20. Glezen WP, Alpers M. Maternal immunization. Clin Infect Dis 1999;28:219-224 (Pubitemid 29241203)
21. Vasiliauskas EA, Church JA, Silverman N, Barry M, Targan SR, Dubinsky MC. Case report: evidence for transplacental transfer of the maternally administered infliximab to the newborn. Clin Gastroenterol Hepatol 2006;4:1255-1258 (Pubitemid 44512222)
22. Giroir BP, Peppel K, Silva M, Beutier B. The biosynthesis of tumor necrosis factor during pregnancy: studies with a CAT reporter transgene and TNF inhibitors. Eur Cytokine Netw 1992;3:533-538
23. Etanercept (Enbrel) package insert. Amgen Wyeth. Manufactured by Immunex Corp., Thousand Oaks, CA, USA, 6/05/2003. Internet. Available from: www.enbrel.com. Accessed Oct 31 2008.
24. Nonclinical Pharmacology and Toxicology Review of BLA 98-0286. Data on file at the FDA. Internet. Available at: http://www.fda.gov/cder/biologics/ review/etanimm110298r5.pdf. Accessed Oct 31 2008.
25. Infliximab (Remicade) package insert. Johnson & Johnson. Manufactured by Centocor, Inc., Malvern, PA, USA. Internet. Available from: www.remicade.com. Accessed Oct 31 2008.
26. Brent RL, Holmes LB. Clinical and basic science lessons from the thalidomide tragedy: what have we learned about the causes of limb defects? Teratology 1988;38:241-251
27. Lenz W. A short history of thalidomide embryopathy. Teratology 1988;38:203-215 (Pubitemid 18230120)
28. Newman CG. Teratogen update: clinical aspects of thalidomide embryopathy - a continuing preoccupation. Teratology 1985:32:133-144 (Pubitemid 15033546)
29. Koren G, Nava-Ocampa AA, Moretti ME, Sussman R, Nulman I. Major malformations with valproic acid. Can Fam Physician 2006;52:441-447 (Pubitemid 44405808)
30. Ardinger HH, Atkin JF, Blackston RD, et al. Verification of the fetal valproate syndrome phenotype. Am J Med Genet 1988;29:171-185 (Pubitemid 18036040)
31. Kallen B. Valproic acid is known to cause hypospadias in man but does not reduce anogenital distance or causes hypospadias in rats. Basic Clin Pharmacol Toxicol 2004;94:51-54 (Pubitemid 38428820)
32. Strangfeld A, Listing J, Rau R, et al. Pregnancy outcome after exposure to biologics: results from the German biologics register RABBIT [abstract]. Arthritis Rheum 2007;56 Suppl:S311.
33. Katz JA, Antoni C, Keenan GF, Smith DE, Jacobs SJ, Lichtenstein GR. Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis. Am J Gastroenterol 2004;99:2385-2392 (Pubitemid 40039370)
34. Hyrich KL, Symmons DP, Watson KD, Silman AJ; British Society for Rheumatology Biologics Register. Pregnancy outcome in women who were exposed to anti-tumor necrosis factor agents: results from a national population register. Arthritis Rheum 2006;54:2701-2702
35. Mahadevan U, Kane S, Sandborn WJ, et al. Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease. Aliment Pharmacol Ther 2005;21:733-738 (Pubitemid 40469001)
36. Roux CH, Brocq O, Brocq O, Breuil V, Albert C, Euller-Ziegler L. Pregnancy in rheumatology paitents exposed to anti-tumor necrosis factor (TNF)-alpha therapy. Rheumatology Oxford 2007;46:695-698 (Pubitemid 46523319)
37. Castori M, Rinaldi R, Capocaccia P, Roggini M, Grammatico P. VACTERL association and maternal diabetes: a possible causal relationship? Birth Defects Res A Clin Mol Teratol 2008;82:169-172
38. Hoffman JIE. Natural history of congenital heart disease. Problems in its assessment with special reference to ventricular septal defects. Circulation 1968;37:97-125.
39. Division of Birth Defects and Developmental Disabilities, National Center for Environmental Health, CDC. Internet. Available from: http://www.cdc.gov/ ncbddd/bd/monitoring.htm
40. Bisceglia M, Galliani CA, Senger C, Stallone C, Sessna A. Renal cystic diseases: a review. Adv Anat Pathol 2006;13:26-56. (Pubitemid 44357146)
41. Shetty SC, Gupta S, Cherian M, Chary G, Shariff S. Mature teratoma of the nasal vestibule: a case report. Ear Nose Throat J 2000;79:620-623 (Pubitemid 30660388)
42. Das BB, Nagaraj A, Rao HA, Rajagowda KB. Tracheal agenesis: Report of three cases and review of literature. Am J Perinatol 2002;19:395-439 (Pubitemid 35231566)
43. Michigan Birth Defects Registry, Michigan Department of Community Health. Internet. Available from: www.mdch.state.mi.us/pha/osr/index.asp?Id=7. Accessed Oct 31 2008.
44. Antonarakis SE, Peterson MB, McInnis MG, et al. The meiotic stage of nondisjunction in trisomy 21: determination by using DNA polymorphisms. Am J Hum Genet 1992;5:1411-1416
45. Choi H, Kim KM, Koh SK, et al. A survey of externally recognizable genitourinary anomalies in Korean newborns. J Korean Med Sci 1989;4:13-21. (Pubitemid 19197815)
46. Forrester MB, Merz RD. Descriptive epidemiology of cystic hygroma: Hawaii, 1986 to 1999. South Med J 2004;97:631-636
47. DeRespinis PA, Caputo AR, Wagner RS, Guo S. Duane's retraction syndrome. Survey Ophthalmol 1993;38:258-288 (Pubitemid 23362701)
48. Engesaeter LB. Increasing incidence of clubfoot: changes in the genes or the environment? Acta Orthop 2006;77:837-838
49. Dec GW, Fuster V. Idiopathic dilated cardiomyopathy. N Engl J Med 1994;331:1564. (Pubitemid 24366905)
50. Brewer CM. Survival in trisomy 13 and trisomy 18 cases ascertained from population based registers. J Med Genet 2002;39:54.
51. Statistics Canada. Vital statistics, Vol.1. Births and deaths: Table 1. Vital statistics summary, 1984 and 1985 (Catalogue 84-204). Ottawa: Minister of Supply and Services; 1985.
52. Kiprov DD, Calvin RB, McLuskey RT. Focal and segmental glomerulosclerosis and proteinuria associated with unilateral renal agenesis. Lab Invest 1982;46:275-281
53. Nordlow W. Squint: the frequency of onset at different ages and the incidence of some associated defects in a Swedish population. Acta Ophthalmol 1964;42:1015-1037
54. Salomon R, Attie T, Pelet A, et al. Germline mutations of the RET ligand GDNF are not sufficient to cause Hirschsprung disease. Nat Genet 1996;14:345-347
55. Xu L, Wang Y, Jonas JB. Incidence of nonarteritic anterior ischemic optic neuropathy in adult Chinese: the Beijing Eye Study. Eur J Opthalmol 2007;17:459-460 (Pubitemid 47056311)
56. Kacinski M, Swierczynska A, Jaworek M, Zajac A. Non traumatic spinal syndromes in children. Przegl Lek 2005;62:1281-1286
57. Rahi JS, Dezateux C. National cross sectional study of detection of congenital and infantile cataract in the United Kingdom: role of childhood screening and surveillance. BMJ 1999;318:362-365 (Pubitemid 29192083)
58. Kemper AR, Downs SM. A cost-effectiveness of newborn hearing screening strategies. Arch Pediatr Adolesc Med 2000;154:484-488 (Pubitemid 30252654)
59. Robinson GC, Jan JE, Kinnis C. Congenital ocular blindness in children, 1945 to 1984. Am J Dis Child 1987;141:1321-1324
60. Rahbar R, Rouillon I, Roger G, et al. The presentation and management of laryngeal cleft: a 10-year experience. Arch Otolaryngol Head Neck Surg 2006;132:1335-1341 (Pubitemid 44956612)